🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EFFECT OF ESWT ON BREAST-CANCER RELATED LYMPHEDEMA

RecruitingNAAges 18 Years - anyFemaleAnkara City Hospital Bilkent
NCT07854262 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) combined with complete decongestive therapy (CDT) compared with CDT alone in patients with breast cancer-related lymphedema. Female patients with unilateral Stage II upper-extremity lymphedema related to breast cancer will be included. Participants will receive either complete decongestive therapy alone or complete decongestive therapy combined with extracorporeal shock wave therapy. Clinical outcomes will be evaluated before treatment, immediately after treatment, and at 1 and 3 months after treatment. Primary outcomes will include limb circumference difference, volumetric measurements, and ultrasonographic assessment of skin and subcutaneous tissue thickness. Secondary outcomes will include upper-extremity function, quality of life, and pain.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria:Female patients with unilateral upper-extremity lymphedema related to breast cancer. At least 2 years have elapsed since the diagnosis of breast cancer, cancer treatment has been completed, and cure has been documented during oncology follow-up. Stage II lymphedema according to the International Society of Lymphology classification. Duration of lymphedema of less than 4 years. Voluntary participation in the study. - Exclusion Criteria: Poor general health status. Open wounds, sensory deficits, or other conditions in the treatment area that may constitute a contraindication to treatment. Active infection. Presence of metastasis. Bilateral breast cancer. Bilateral lymphedema. Use of anticoagulant therapy or presence of a coagulation disorder. Cognitive impairment that may prevent completion of study assessment procedures. Physical therapy, including electrotherapy or exercise therapy, ESWT, or regular use of nonsteroidal anti-inflammatory drugs within the previous 6 months. Systemic inflammatory or autoimmune disorders such as rheumatoid arthritis or systemic lupus erythematosus. \-
💊

What it tests

  • Complete Decongestive Therapy
  • Extracorporeal Shock Wave Therapy
📍

Where

1 site
Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy